Lactose (India), a company in the Pharmaceuticals industry, reported revenue of ₹47 crore and net profit of ₹2.37 crore for the June 2026 quarter.
Lactose (India) (BSE: LACTOSE) closed at ₹88.90 on 20 Nov 2026, down 29.8% over the past year. Its market capitalisation is ₹112 crore and it trades at 16.1 times earnings.
Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.